Defective protein degradation in genetic disorders

Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta. Molecular basis of disease 2022-05, Vol.1868 (5), p.166366-166366, Article 166366
1. Verfasser: Castel, Pau
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 166366
container_issue 5
container_start_page 166366
container_title Biochimica et biophysica acta. Molecular basis of disease
container_volume 1868
creator Castel, Pau
description Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field. •Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.
doi_str_mv 10.1016/j.bbadis.2022.166366
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8977116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0925443922000291</els_id><sourcerecordid>2629057293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotlbfQGSWbqbmMpNJNoLUKxTcKLgLmeRMTZlOajIt-PamtFbdmM0h5_L_53wInRM8Jpjwq_m4rrV1cUwxpWPCOeP8AA2JqGROOX47REMsaZkXBZMDdBLjHKfHK3yMBqwkpcBEDhG9hQZM79aQLYPvwXWZhVnQVvfOd1n6zqCD3pksWflgIcRTdNToNsLZLo7Q6_3dy-Qxnz4_PE1uprkpOOvzuikaa4URBgwjmGJjsGW8YFxooWVNBE_71KUoakl4BbzRLOVIRVLWUs5G6Hqru1zVC7AGuj7oVi2DW-jwqbx26m-lc-9q5tdKyKoiZCNwuRMI_mMFsVcLFw20re7Ar6KinEpcVlSy1FpsW03wMQZo9jYEqw1uNVdb3GqDW21xp7GL3yvuh775_twACdTaQVDROOgMWBcSdmW9-9_hCy0Xkt8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2629057293</pqid></control><display><type>article</type><title>Defective protein degradation in genetic disorders</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Castel, Pau</creator><creatorcontrib>Castel, Pau</creatorcontrib><description>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field. •Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</description><identifier>ISSN: 0925-4439</identifier><identifier>ISSN: 1879-260X</identifier><identifier>EISSN: 1879-260X</identifier><identifier>DOI: 10.1016/j.bbadis.2022.166366</identifier><identifier>PMID: 35158019</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>BTB proteins ; Congenital disorders ; CRL3 ; Cullin 3 ; Cullin Proteins - genetics ; Cullin Proteins - metabolism ; LZTR1 ; Proteolysis ; Ubiquitin ; Ubiquitination</subject><ispartof>Biochimica et biophysica acta. Molecular basis of disease, 2022-05, Vol.1868 (5), p.166366-166366, Article 166366</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</citedby><cites>FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbadis.2022.166366$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35158019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castel, Pau</creatorcontrib><title>Defective protein degradation in genetic disorders</title><title>Biochimica et biophysica acta. Molecular basis of disease</title><addtitle>Biochim Biophys Acta Mol Basis Dis</addtitle><description>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field. •Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</description><subject>BTB proteins</subject><subject>Congenital disorders</subject><subject>CRL3</subject><subject>Cullin 3</subject><subject>Cullin Proteins - genetics</subject><subject>Cullin Proteins - metabolism</subject><subject>LZTR1</subject><subject>Proteolysis</subject><subject>Ubiquitin</subject><subject>Ubiquitination</subject><issn>0925-4439</issn><issn>1879-260X</issn><issn>1879-260X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotlbfQGSWbqbmMpNJNoLUKxTcKLgLmeRMTZlOajIt-PamtFbdmM0h5_L_53wInRM8Jpjwq_m4rrV1cUwxpWPCOeP8AA2JqGROOX47REMsaZkXBZMDdBLjHKfHK3yMBqwkpcBEDhG9hQZM79aQLYPvwXWZhVnQVvfOd1n6zqCD3pksWflgIcRTdNToNsLZLo7Q6_3dy-Qxnz4_PE1uprkpOOvzuikaa4URBgwjmGJjsGW8YFxooWVNBE_71KUoakl4BbzRLOVIRVLWUs5G6Hqru1zVC7AGuj7oVi2DW-jwqbx26m-lc-9q5tdKyKoiZCNwuRMI_mMFsVcLFw20re7Ar6KinEpcVlSy1FpsW03wMQZo9jYEqw1uNVdb3GqDW21xp7GL3yvuh775_twACdTaQVDROOgMWBcSdmW9-9_hCy0Xkt8</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Castel, Pau</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220501</creationdate><title>Defective protein degradation in genetic disorders</title><author>Castel, Pau</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-bf4fdd8c8cec31020cc0d364368a8a9b186000b584b9167e6fa318617100bd263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>BTB proteins</topic><topic>Congenital disorders</topic><topic>CRL3</topic><topic>Cullin 3</topic><topic>Cullin Proteins - genetics</topic><topic>Cullin Proteins - metabolism</topic><topic>LZTR1</topic><topic>Proteolysis</topic><topic>Ubiquitin</topic><topic>Ubiquitination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castel, Pau</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castel, Pau</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defective protein degradation in genetic disorders</atitle><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle><addtitle>Biochim Biophys Acta Mol Basis Dis</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>1868</volume><issue>5</issue><spage>166366</spage><epage>166366</epage><pages>166366-166366</pages><artnum>166366</artnum><issn>0925-4439</issn><issn>1879-260X</issn><eissn>1879-260X</eissn><abstract>Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field. •Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35158019</pmid><doi>10.1016/j.bbadis.2022.166366</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0925-4439
ispartof Biochimica et biophysica acta. Molecular basis of disease, 2022-05, Vol.1868 (5), p.166366-166366, Article 166366
issn 0925-4439
1879-260X
1879-260X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8977116
source MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals
subjects BTB proteins
Congenital disorders
CRL3
Cullin 3
Cullin Proteins - genetics
Cullin Proteins - metabolism
LZTR1
Proteolysis
Ubiquitin
Ubiquitination
title Defective protein degradation in genetic disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A20%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defective%20protein%20degradation%20in%20genetic%20disorders&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Molecular%20basis%20of%20disease&rft.au=Castel,%20Pau&rft.date=2022-05-01&rft.volume=1868&rft.issue=5&rft.spage=166366&rft.epage=166366&rft.pages=166366-166366&rft.artnum=166366&rft.issn=0925-4439&rft.eissn=1879-260X&rft_id=info:doi/10.1016/j.bbadis.2022.166366&rft_dat=%3Cproquest_pubme%3E2629057293%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2629057293&rft_id=info:pmid/35158019&rft_els_id=S0925443922000291&rfr_iscdi=true